674 related articles for article (PubMed ID: 32437659)
1. Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection.
Netea MG; Giamarellos-Bourboulis EJ; Domínguez-Andrés J; Curtis N; van Crevel R; van de Veerdonk FL; Bonten M
Cell; 2020 May; 181(5):969-977. PubMed ID: 32437659
[TBL] [Abstract][Full Text] [Related]
2. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
Front Immunol; 2020; 11():1022. PubMed ID: 32574260
[TBL] [Abstract][Full Text] [Related]
3. Immune responses and pathogenesis of SARS-CoV-2 during an outbreak in Iran: Comparison with SARS and MERS.
Rokni M; Ghasemi V; Tavakoli Z
Rev Med Virol; 2020 May; 30(3):e2107. PubMed ID: 32267987
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiology of COVID-19: Why Children Fare Better than Adults?
Dhochak N; Singhal T; Kabra SK; Lodha R
Indian J Pediatr; 2020 Jul; 87(7):537-546. PubMed ID: 32410003
[TBL] [Abstract][Full Text] [Related]
5. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
6. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity.
Schijns V; Lavelle EC
Eur J Immunol; 2020 Jul; 50(7):932-938. PubMed ID: 32438473
[TBL] [Abstract][Full Text] [Related]
7. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
[TBL] [Abstract][Full Text] [Related]
8. The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.
Zhang YY; Li BR; Ning BT
Front Immunol; 2020; 11():2033. PubMed ID: 32922406
[TBL] [Abstract][Full Text] [Related]
9. Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.
Chu H; Chan JF; Wang Y; Yuen TT; Chai Y; Hou Y; Shuai H; Yang D; Hu B; Huang X; Zhang X; Cai JP; Zhou J; Yuan S; Kok KH; To KK; Chan IH; Zhang AJ; Sit KY; Au WK; Yuen KY
Clin Infect Dis; 2020 Sep; 71(6):1400-1409. PubMed ID: 32270184
[TBL] [Abstract][Full Text] [Related]
10. Mitigating Coronavirus Induced Dysfunctional Immunity for At-Risk Populations in COVID-19: Trained Immunity, BCG and "New Old Friends".
Kleen TO; Galdon AA; MacDonald AS; Dalgleish AG
Front Immunol; 2020; 11():2059. PubMed ID: 33013871
[TBL] [Abstract][Full Text] [Related]
11. Coronaviruses: Is Sialic Acid a Gate to the Eye of Cytokine Storm? From the Entry to the Effects.
Wielgat P; Rogowski K; Godlewska K; Car H
Cells; 2020 Aug; 9(9):. PubMed ID: 32854433
[TBL] [Abstract][Full Text] [Related]
12. Covid-19: Perspectives on Innate Immune Evasion.
Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
Front Immunol; 2020; 11():580641. PubMed ID: 33101306
[TBL] [Abstract][Full Text] [Related]
13. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
[TBL] [Abstract][Full Text] [Related]
14. Could the Induction of Trained Immunity by β-Glucan Serve as a Defense Against COVID-19?
Geller A; Yan J
Front Immunol; 2020; 11():1782. PubMed ID: 32760409
[TBL] [Abstract][Full Text] [Related]
15. The many faces of the anti-COVID immune response.
Vardhana SA; Wolchok JD
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32353870
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2: previous coronaviruses, immune response, and development of vaccines.
De León-Rodríguez SG; Hernández-Rico B; Olmo-Vázquez GD; Cruz-Dávalos I; Bonifaz LC
Bol Med Hosp Infant Mex; 2020; 77(5):252-261. PubMed ID: 33064679
[TBL] [Abstract][Full Text] [Related]
17. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
Front Immunol; 2020; 11():581338. PubMed ID: 33123167
[TBL] [Abstract][Full Text] [Related]
18. Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques.
Deng W; Bao L; Liu J; Xiao C; Liu J; Xue J; Lv Q; Qi F; Gao H; Yu P; Xu Y; Qu Y; Li F; Xiang Z; Yu H; Gong S; Liu M; Wang G; Wang S; Song Z; Liu Y; Zhao W; Han Y; Zhao L; Liu X; Wei Q; Qin C
Science; 2020 Aug; 369(6505):818-823. PubMed ID: 32616673
[TBL] [Abstract][Full Text] [Related]
19. Weak Induction of Interferon Expression by Severe Acute Respiratory Syndrome Coronavirus 2 Supports Clinical Trials of Interferon-λ to Treat Early Coronavirus Disease 2019.
O'Brien TR; Thomas DL; Jackson SS; Prokunina-Olsson L; Donnelly RP; Hartmann R
Clin Infect Dis; 2020 Sep; 71(6):1410-1412. PubMed ID: 32301957
[No Abstract] [Full Text] [Related]
20. Bioinformatic analysis and identification of single-stranded RNA sequences recognized by TLR7/8 in the SARS-CoV-2, SARS-CoV, and MERS-CoV genomes.
Moreno-Eutimio MA; López-Macías C; Pastelin-Palacios R
Microbes Infect; 2020; 22(4-5):226-229. PubMed ID: 32361001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
